Mar 19, 2026 | Dietary Supplements, FDA and USDA Regulatory Update
FDA to Host Public Meeting on the Scope of Dietary Supplement Ingredients FDA Announces Public Meeting on Dietary Supplement Ingredient Scope The U.S. Food and Drug Administration will host a public meeting on March 27, 2026, focused on exploring the scope of dietary...
Mar 18, 2026 | FDA and USDA Regulatory Update, Foods
FDA Withdraws Temporary COVID FSMA Guidances Related to Onsite Audits FDA Ends COVID-Era Flexibility for FSMA Onsite Audit Requirements The U.S. Food and Drug Administration has announced it is withdrawing two temporary guidances issued during the COVID-19 public...
Mar 9, 2026 | Biologics, FDA and USDA Regulatory Update
FDA Announces New Steps to Streamline Biosimilar Development FDA Takes Additional Steps to Support Biosimilar Development The U.S. Food and Drug Administration has announced new actions aimed at streamlining the development of biosimilar medicines and improving access...
Mar 9, 2026 | Drugs, FDA and USDA Regulatory Update
FDA Finalizes Rule Standardizing National Drug Code Format FDA Final Rule Revises National Drug Code Format and Barcode Requirements FDA has issued a final rule revising the format of the National Drug Code (NDC) and updating certain drug label barcode requirements....
Mar 9, 2026 | Drugs, FDA and USDA Regulatory Update
FDA Issues Guidance on Responding to Form 483 Observations Following Drug CGMP Inspections FDA Releases Guidance on Responding to Form 483 Observations The U.S. Food and Drug Administration has issued a guidance document titled “Responding to FDA Form 483 Observations...
Mar 4, 2026 | Dietary Supplements, FDA and USDA Regulatory Update, Foods
FDA Announces Public Meeting on Dietary Supplement Innovation and Ingredient Scope FDA to Hold Public Meeting on Dietary Supplement Innovation and Ingredient Scope The U.S. Food and Drug Administration has announced an upcoming public meeting focused on dietary...
